|
Expression Analysis has entered
into a variety of alliances and collaborations
with prominent organizations to advance the use
of genomic technology. Either through a Strategic
Alliance or a Co-Marketing Alliance, the unique
core competencies of both EA and our complimentary
organizations are integrated to provide our customers
a network of comprehensive microarray-based services
and solutions. By establishing quality and regulatory
standards in microarray processing and bioinformatics,
and by merging with those standards the skills
and expertise of our alliance partnerships, EA
is able to create a value chain that serves the
drug discovery, drug development, and clinical
diagnostics markets.
Contact EA: Find
out how your organization and EA can advance genomic
technology together. Please call us at
919.405.CAGT (2248) or email
us!
Strategic
Alliances
 Affymetrix
Affymetrix
technology makes possible the identification and
analysis of genetic information for the life science
industry. The Company manufactures, sales and
services the GeneChip platform and also offers
various additional types of microarray technology.
Utilized by scientists and researchers in the
biotechnology, diagnostic, and pharmaceutical
industries—to name a few—Affymetrix
technologies allow for the investigation and management
of genetic data and the advancement of research
and development efforts. Visit
the website
Affymetrix and Expression
Analysis
Expression Analysis operates a full-service microarray
genetics testing and analysis laboratory dedicated
to providing clients with the highest quality
genomic processing and data analysis services
using Affymetrix GeneChip® microarray technology.
This technology applies the principles of semiconductor
technology to life sciences, making it possible
to qualitatively and quantitatively measure gene
expression levels in a number of biologically
relevant organisms, quickly and with more reliable
results. Affymetrix also serves as a strategic
partner for certain key Expression Analysis initiatives.
Contact
Affymetrix
Tel:
888-DNA-CHIP (888-362-2447)
www.affymetrix.com
Duke
University
The
Duke Microarray Core Facility, a primary component
of the Duke Center for Genome Technology, allows
Duke Investigators genomic testing services aimed
to enhance their research and development efforts.
The Center provides Investigators with genomic
data management and analysis services, as well
as the probe development, hybridization, and scanning
services offered exclusively by Expression Analysis.
Visit
the website
Duke University and Expression
Analysis
Expression Analysis serves as the core Affymetrix
microarray facility for Duke University. While
serving as its core, Expression Analysis has been
able to reduce the cost while improving the quality
and turnaround time for Duke Researchers.
Contact
Duke University
Duke
Microarray Core Facility
Dr.
Holly Dressman, Director
Tel:
919-684-8224
http://mgm.duke.edu/genome/dna_micro/
 Constella
Group, LLC
Constella
Group is a leading global provider of outsourced
health intelligence and public health and technology
services. It excels in managing a wide range of
programs to help public-sector, commercial, and
nonprofit clients identify and address critical
issues that affect human health. Constella's three
business units--Health Sciences, Futures Group,
and Clinical Informatics--are distinguished by
their ability to design and execute diverse and
customized client solutions that integrate health-care
technology, project management, and policy expertise
across public and private sectors throughout the
United States and the world. In business for more
than 30 years, Constella is passionate about applying
its resources, skills, and knowledge toward a
singular, yet expansive vision of enhancing human
health around the world, every day. The company's
approximately 1,100 employees offer clients a
diversity of skills and experience in many professional,
scientific, and technical disciplines. Employees
serve clients from company headquarters in Durham,
N.C., from U.S. offices in Research Triangle Park,
N.C., Washington, D.C; Bethesda, Frederick and
Silver Spring, Md.; Glastonbury, Conn.; Atlanta,
Ga.; and Morgantown, W.Va.; from a U.K. office
in Bath and one in New Delhi, India; and from
client sites and other offices across the world.
For more information, visit www.constellagroup.com
and www.futuresgroup.com.
Constella Group, LLC and Expression Analysis
Expression
Analysis has a strategic alliance with Constella
Biomedical Informatics, a division of the Constella
Group, Inc., a Durham, N.C. based professional
human health organization, to assist in genomic
data warehousing and management in a 21 CFR Part
11 compliant environment.
Contact
Constella, LLC
Corporate
Headquarters: Durham, NC
Tel:
919-544-8500
www.constellagroup.com
 Covance
Central Labs
Covance, with
headquarters in Princeton, New Jersey, is one
of the world's largest and most comprehensive
drug development services companies with annual
revenues greater than $1 billion, global operations
in 17 countries, and approximately 6,700 employees
worldwide. Information on Covance’s products
and services, recent press releases, and SEC filings
can be obtained through its website. Visit
the website
Covance Central Labs and
Expression Analysis
Our Strategic Agreement with Covance’s Central
Laboratory Services unit, the world’s largest
clinical trial laboratory services provider, will
offer genomic microarray testing as an integral
part of Covance’s preclinical and clinical
trial services. The agreement combines Covance’s
global Central Laboratory clinical trials capabilities
with Expression Analysis’ pharmacogenomic
microarray testing and statistical expertise to
enable pharmaceutical and biotechnology firms
to conduct genomic microarray testing for patients
anywhere in the world.
Contact
Covance Central Labs
Tel:
888-Covance (268-2623)
www.covance.com
GenVault
GenVault
is the leader in smart biosample management, providing
integrated
biosample archiving and retrieval solutions based
on best
practices in order to provide a scalable and reliable
alternative to
traditional
freezer networks and DNA purification systems.
Visit
the website
GenVault and Expression
Analysis
The utilization of GenVault's BioSample Management
System enables researchers to recover DNA from
dry state storage and provide high quality DNA
for gene expression processing and analysis at
Expression Analysis.
Contact
GenVault
Tel:
(760) 268-5200
www.genvault.com
Luminex
Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
Luminex & Expression Analysis
Expression Analysis also offers focused expression services for smaller sets of genes using the Luminex system.
Contact Luminex
Tel:
888.219.8020
www.luminexcorp.com
Co-Marketing Alliances
Sapio Sciences, LLC
Sapio Sciences has extensive bioinformatics and
biological expertise with
significant experience in analyzing genotype
data for our valued customers. Sapio Sciences
provides highly detailed reports analyzing experimental
data from both a quantitative and a biological
perspective. Visit
the website
Sapio Sciences & Expression
Analysis
Sapio Sciences Exemplar advanced genetic analysis
tool for genotyping is compatible with data output
from the Affymetrix 10k and 100k array sets. As
Expression Analysis has expanded its pharmacogenomics
testing services to include Genotyping using the
Affymetrix GeneChip® Mapping 10K 2.0 Array
and the Affymetrix 100k Array set, Sapio Sciences
Exemplar is of benefit to researchers who want
logical, easy-to-understand models of genetic
data and clinical metrics.
Contact Sapio Sciences
Tel: 717-870-7928
www.sapiosciences.com
|
